HopeStage
Back to all studies
CompletedNCT02801604

Long-Term Course After Switching to Dexamphetamine in ADHD

About this titleRead the official source — NCT02801604
Observational studyAges 6 years–215 monthsGermany
The study in practice

Understand this study

Who was this study for?

This study was for people with ADHD. Listed age limits: 6 years to 215 months. Other eligibility criteria applied.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJune 2016
Recruitment status
Completed
Enrollment listed in the registry
150
Sponsor
Medice Arzneimittel Pütter GmbH & Co KG
Sponsor type
Other organization
Study type
Observational
Intervention type
Interview / survey / observational
Study phase
Not clearly listed
Locations
Germany
Age range
From 6 Years to 215 Months
Official registry ID
NCT02801604
Official title
Show the full official title

Attentin® in Children and Adolescents With ADHD - A Non-interventional Study

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Mainz

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Medice Arzneimittel Pütter GmbH & Co KG.

Who was this study for?

This study was for people with ADHD. Listed age limits: 6 years to 215 months. Other eligibility criteria applied.

Want to explore more studies?

Explore studies